These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10372713)

  • 21. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor.
    Orth DN; DeBold CR; DeCherney GS; Jackson RV; Alexander AN; Rivier J; Rivier C; Spiess J; Vale W
    J Clin Endocrinol Metab; 1982 Nov; 55(5):1017-9. PubMed ID: 6288750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing's disease.
    Pieters GF; Hermus AR; Meijer E; Smals AG; Kloppenborg PW
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1122-6. PubMed ID: 2555381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What can predict postoperative "endocrinological cure" in Cushing's disease?
    Nishizawa S; Oki Y; Ohta S; Yokota N; Yokoyama T; Uemura K
    Neurosurgery; 1999 Aug; 45(2):239-44. PubMed ID: 10449067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early postoperative evaluation in patients with Cushing's disease: usefulness of ovine corticotropin-releasing hormone test in the prediction of recurrence of disease.
    Vignati F; Berselli ME; Loi P
    Eur J Endocrinol; 1994 Mar; 130(3):235-41. PubMed ID: 8156095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRH in Cushing's syndrome.
    Müller OA; Stalla GK; von Werder K
    Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    Newell-Price J; Morris DG; Drake WM; Korbonits M; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1640-5. PubMed ID: 11932295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corticotropin releasing factor: a new tool for the differential diagnosis of Cushing's syndrome.
    Müller OA; Stalla GK; von Werder K
    J Clin Endocrinol Metab; 1983 Jul; 57(1):227-9. PubMed ID: 6304135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.
    Oldfield EH; Doppman JL; Nieman LK; Chrousos GP; Miller DL; Katz DA; Cutler GB; Loriaux DL
    N Engl J Med; 1991 Sep; 325(13):897-905. PubMed ID: 1652686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H; Tamura T
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nocturnal serum thyrotropin surge is abolished in patients with adrenocorticotropin (ACTH)-dependent or ACTH-independent Cushing's syndrome.
    Bartalena L; Martino E; Petrini L; Velluzzi F; Loviselli A; Grasso L; Mammoli C; Pinchera A
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1195-9. PubMed ID: 1851180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Cushing's syndrome: diurnal rhythm and responses to various stimuli.
    Orth DN; Peterson ME; Drucker WD
    Endocrinology; 1988 Apr; 122(4):1250-62. PubMed ID: 3126032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential diagnosis and management of Cushing's syndrome.
    Tsigos C; Chrousos GP
    Annu Rev Med; 1996; 47():443-61. PubMed ID: 8712794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of serum leptin levels in Cushing's syndrome.
    Widjaja A; Schürmeyer TH; Von zur Mühlen A; Brabant G
    J Clin Endocrinol Metab; 1998 Feb; 83(2):600-3. PubMed ID: 9467580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome.
    Masuzaki H; Ogawa Y; Hosoda K; Miyawaki T; Hanaoka I; Hiraoka J; Yasuno A; Nishimura H; Yoshimasa Y; Nishi S; Nakao K
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2542-7. PubMed ID: 9253331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease.
    Pieters GF; Smals AG; Goverde HJ; Pesman GJ; Meyer E; Kloppenborg PW
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1188-97. PubMed ID: 6290524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.